The Health Council of the Netherlands recommends rotavirus vaccination for children despite not being cost-effective

Netherlands
NITAGs
31 October 2017

Rotavirus infections cause thousands of hospitalisations a year amongst young children. Vaccination can prevent a large part of these, as well as almost completely banishing mortality from rotavirus. These benefits outweigh the small risk of a serious complication from vaccination, according to the Health Council.

nl.png

Therefore, its advice is to vaccinate children against rotavirus. Children who are premature, have a low birth weight, or have a congenital disorder should be vaccinated in any case. For these children, the consequences of rotavirus infection are most severe. The council would also welcome universal vaccination: this would lead to more health benefits, but is not cost-effective at the current vaccine prices.

Documents to download

Related News & Events

  • Kazakhstan
    NITAGs

    Voice from the field : Lyazzat Yeraliyeva

    14.11.2017

    The NITAG of Kazakhstan recently launched their website to make their recommendations available and promote the work of the members. Lyazzat Yeraliyeva, former Chair of the NITAG, now acts as the Deputy Chair.

    Read more
  • NITAGs

    Strenghtening NITAGs through the Partnership for Influenza Vaccine Introduction

    07.11.2017

    The Partnership for Influenza Vaccine Introduction (PIVI), based at The Task Force for Global Health (TFGH), is an innovative public/private program that partners with the Centers for Disease Control and Prevention (CDC), Ministries of Health, corporate partners and others to create sustainable, routine, seasonal influenza vaccination programs in low- and middle-income countries.   PIVI’s goal is to create routine, seasonal influenza vaccination programs to protect communities from the impacts of both seasonal and pandemic influenza. Working with countries’ Ministries of Health, as well as with other technical collaborators, PIVI supports capacity building for NITAGs to make evidence-based vaccine policy decision making.  These activities are coordinated with NITAG strengthening work carried out through other projects and cooperative funding agreements between countries and CDC’s Influenza and Global Immunization Divisions.  The work is also closely coordinated with NITAG focal points in WHO regional and country offices.  

    Read more
  • Costa Rica
    NITAGs

    Costa Rica introduces two new vaccines into the national immunization program

    16.10.2017

    October 2017 marks the introduction of the rotavirus and human papillomavirus (HPV) vaccines in Costa Rica’s immunization program. This decision results from the recommendations of the country National Immunization Technical Advisory Group (NITAG). Since 2001, Costa Rica’s NITAG, which is called Comisión Nacional de Vacunación y Epidemiología (National Commission on Vaccination and Epidemiology), is in charge of establishing and periodically updating the national immunization schedule as well as formulating overall policies and strategies for immunization. In order to issue the recommendations, the NITAG conducted cost-effectiveness studies that were then approved by its members.

    Read more